WASHINGTON (AP) — The U.S. Department of Health and Human Services on Thursday unveiled a series of regulatory actions ...

Learn how an Abbreviated New Drug Application (ANDA) helps generic drugs get FDA approval without clinical trials, ensuring safety and bioequivalence with brand-name drugs.

President Donald Trump’s historic move to direct the reclassification of marijuana on Thursday has elicited a wave of ...

On Thursday, President Donald Trump signed an executive order directing federal agencies to expedite the reclassification of cannabis to a Schedule III drug. Local cannabis businesses that navigate ...

Under new proposed rules, hospitals would lose federal funding if they offer treatments including puberty blockers, hormone ...

“Evidence shows sex-rejecting puberty blockers, cross-sex hormones, and surgeries are dangerous. Providers have an obligation ...

Patients with moderate-to-severe plaque psoriasis who took the once-daily pill showed significantly clearer skin compared with those on placebo or the existing therapy apremilast, the company said.

Eli Lilly seeks FDA approval for orforglipron, a once-daily pill shown in trials to help maintain weight loss after stopping ...

Trump's executive order hastens a recategorization of marijuana from a Schedule 1 drug under the 1971 Controlled Substances Act to Schedule 3.

President Donald Trump on Thursday signed an executive order downgrading cannabis from a Schedule I substance — a category ...

It includes hormone treatments that attempt to masculinize girls with testosterone and feminize boys with estrogen and puberty blockers, ...